| abstract |
The invention relates to novel piperazine derivatives of general formula (I), wherein V, W, n, R, R', i, j, Y and Z have the designation cited in the description. The inventive compounds are characterised by a diazacycloalkane substituent. Said compounds exhibit a particular action in terms of the destabilisation of androgen receptors, and can be used, for example, for the treatment of prostatic cancer. |